Clinical Trial Update: Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing docetaxel plus gemcitabine versus docetaxel plus cisplatin in patients with metastatic or locally advanced pancreatic cancer …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED